Ticker archive · $VRTX

$VRTX Filing Signals & Market Reactions

Delayed, SEO-crawlable recaps of AI-scored catalysts for $VRTX — including observed post-filing price moves. Live streaming stays exclusive to VIP.

? All delayed signals

$VRTX – Vertex Raises FY Revenue Guidance Despite Q3 GAAP EPS Drop to $2.56

VERTEX PHARMACEUTICALS INC / MA
· SEC_8K · All $VRTX
?? Negative AI Sentiment (-1.5 / 10)
  • Q3 revenue grew 12% YoY to $3.44B; FY revenue guidance raised to $13.15B–$13.25B.
  • Diluted GAAP EPS dropped sharply to $2.56 from $4.20 in Q3 2025 as operating expenses surged.
  • Non-GAAP net income was $1.21B compared to $1.24B in the prior-year period.